2024.07.25
PEIJIA MEDICAL'S LICENSING PARTNER, JENAVALVE TECHNOLOGY, INC., IS ACQUIRED···
Peijia Medical commented on the acquisition of JenaValve Technology, Inc. ("···
2024.06.21
Peijia Medical Announced Proposed Share Repurchase in the Open Market
On June 20, Peijia Medical announced that the Board resolved to repurchase share···
2024.06.17
Peijia Medical Announced Audited 2023 Annual Results and Resumption of Trad···
On June 16, Peijia Medical released the announcement of its audited results for ···
2024.06.11
Nearly a Hundred Investors and Analysts Attended the Peijia Medical Corpora···
In late May 2024, Peijia Medical successfully held its 2024 Corporate Day and th···
2024.03.29
PEIJIA MEDICAL ANNOUNCED UNAUDITED 2023 ANNUAL RESULTS
On March 28, 2024, Peijia Medical announced that it would delay the publication ···
2024.01.26
VOLUNTARY ANNOUNCEMENTUNAUDITED OPERATING STATISTICSFOR THE YEAR ENDED DECE···
This announcement is made by Peijia Medical Limited (the “Company”, together wit···
2023.10.31
Peijia Medical Presented Multiple Pipeline Products at TCT 2023 Conference
Transcatheter Cardiovascular Therapeutics 2023 (TCT 2023) conference, the annual···
2023.07.24
UNAUDITED OPERATING STATISTICS FOR THE PERIOD FROM JANUARY 1, 2023 TO JUNE ···
2023.01.18
UNAUDITED OPERATING STATISTICS FOR THE PERIOD FROM JANUARY 1, 2022 TO DECEM···
2022.04.06
Peijia Medical Announced 2021 Annual Results
On March 31, 2022, Peijia Medical Limited (“Peijia Medical” or the “Company”, to···
2022.02.07
Peijia Medical Obtained Exclusive License for JenaValve’s TrilogyTM TAVR Sy···
Peijia Medical Limited (HKEX: 9996) is pleased to announce its strategic investm···
2021.08.31
Peijia Medical Announces 2021 Interim Results
Peijia Medical Announces 2021 Interim ResultsTAVR products TaurusOne® and T···